Edward Arons, PH.D., Esq., Founding Partner, Weiss & Arons, LLP to Speak at The Knowledge Group’s Live Webcast
New York, NY, December 29, 2016 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Edward Arons, PH.D., Esq., Founding Partner, Weiss & Arons, LLP will speak at a 2-hour webcast entitled “Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries Significant Issues Live Webcast” This two-hour event is scheduled on January 12, 2017 @ 12:00pm - 12:00pm ET.
Event Summary:
In the highly competitive and constantly changing market of today, the pharmaceutical industry is looking for suitable ways to extend the profitability of its products up to and beyond patent expiry, so medical device IP Portfolios are becoming increasingly relevant for pharma. Due to the expensive cost associated with the Research and Development (R&D), it is becoming crucial to implement integrated Life Cycle Management (LCM) strategies that would maximize revenues and extend the lifespan of patent portfolios. In cases where patent extension is not an option, and the product is nearing patent cliff, drug innovators are increasingly relying upon medical device IP to decelerate the pace of revenue loss from generic competition.
Without strong product LCM strategies, pharmaceutical companies are more likely to be exposed to legal challenges and revenue risks. In this two-hour live Webcast, a stellar panel assembled by The Knowledge Group will offer a discussion on the most significant issues involving patent portfolio and LCM strategies. The panel will also provide a roadmap through the R&D process and will help the audience understand the best practices in minimizing the risks associated with patent portfolio and lifecycle development.
Key Issues:
· Pharmaceutical and Medical Device Patent Life Cycles – An Overview
· Patent Term Adjustments for Biotech and Pharma
· Role of PTA in Medical Device and Pharma Patent Life Cycle
· Patent Term Extension
· Patentability and Implications for Life Sciences Innovation
· Portfolio Strategies
· Common Risks and Pitfalls
· Up-to-the-minute Regulatory Updates
About Edward “Ted” Arons
Ted Arons' distinctive combination of law and engineering expertise is invaluable to his clients. With 15 years of highly technical experience in engineering and applied mathematics prior to his legal career, Ted brings advanced level of knowledge and practical solutions to every case. Clients can count on his immediate and thorough understanding of their advanced technology products as well as their short- and long-term business needs.
He is highly regarded for providing new ways of looking at technical issues and client advice regarding their products, product pipeline development, acquisitions and licensing. Drawing on his wide-ranging experience in technical areas, guides companies through IP aspects of transactions, including corporate fundraising, renders legal opinions, provides product clearance advice and helps businesses achieve optimal IP positions for corporate growth and fundraising.
Ted's combination of broad and deep scientific background and extensive legal experience enables him to respond to the many intellectual property concerns of his clients. His practice is fully supported by an outstanding staff that works collaboratively on cutting edge legal issues.
Key to his success are strategies to protect the value of IP assets in today's business and legal climate, whether in the U.S. or abroad. Ted brings this integrated approach to transactional work including due diligence, patent portfolio strength assessment and risk management counseling.
About Weiss & Arons LLP
Weiss & Arons LLP is an intellectual property law firm that represents clients that range from small businesses to private equity and from start-ups to multi-billion dollar international corporations. The firm provides IP risk, management advice in connection with technology-based transactions, whether acquisition- or license-based, product development strategy and competitive market positioning. Our scientific expertise and institutional knowledge cover the fields of medtech, electrical engineering, telecommunications, software, material properties, heat transfer and thermodynamics, optics, geophysical exploration, high-energy particle applications and consumer products. The firm is entrusted with IP matters that go before the U.S. Patent and Trademark Office, including the Patent Trials and Appeals Board, the U.S. District Courts and, through decades of collaboration with trusted foreign associates worldwide, courts and rightsgranting agencies throughout the world.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries.
Event Summary:
In the highly competitive and constantly changing market of today, the pharmaceutical industry is looking for suitable ways to extend the profitability of its products up to and beyond patent expiry, so medical device IP Portfolios are becoming increasingly relevant for pharma. Due to the expensive cost associated with the Research and Development (R&D), it is becoming crucial to implement integrated Life Cycle Management (LCM) strategies that would maximize revenues and extend the lifespan of patent portfolios. In cases where patent extension is not an option, and the product is nearing patent cliff, drug innovators are increasingly relying upon medical device IP to decelerate the pace of revenue loss from generic competition.
Without strong product LCM strategies, pharmaceutical companies are more likely to be exposed to legal challenges and revenue risks. In this two-hour live Webcast, a stellar panel assembled by The Knowledge Group will offer a discussion on the most significant issues involving patent portfolio and LCM strategies. The panel will also provide a roadmap through the R&D process and will help the audience understand the best practices in minimizing the risks associated with patent portfolio and lifecycle development.
Key Issues:
· Pharmaceutical and Medical Device Patent Life Cycles – An Overview
· Patent Term Adjustments for Biotech and Pharma
· Role of PTA in Medical Device and Pharma Patent Life Cycle
· Patent Term Extension
· Patentability and Implications for Life Sciences Innovation
· Portfolio Strategies
· Common Risks and Pitfalls
· Up-to-the-minute Regulatory Updates
About Edward “Ted” Arons
Ted Arons' distinctive combination of law and engineering expertise is invaluable to his clients. With 15 years of highly technical experience in engineering and applied mathematics prior to his legal career, Ted brings advanced level of knowledge and practical solutions to every case. Clients can count on his immediate and thorough understanding of their advanced technology products as well as their short- and long-term business needs.
He is highly regarded for providing new ways of looking at technical issues and client advice regarding their products, product pipeline development, acquisitions and licensing. Drawing on his wide-ranging experience in technical areas, guides companies through IP aspects of transactions, including corporate fundraising, renders legal opinions, provides product clearance advice and helps businesses achieve optimal IP positions for corporate growth and fundraising.
Ted's combination of broad and deep scientific background and extensive legal experience enables him to respond to the many intellectual property concerns of his clients. His practice is fully supported by an outstanding staff that works collaboratively on cutting edge legal issues.
Key to his success are strategies to protect the value of IP assets in today's business and legal climate, whether in the U.S. or abroad. Ted brings this integrated approach to transactional work including due diligence, patent portfolio strength assessment and risk management counseling.
About Weiss & Arons LLP
Weiss & Arons LLP is an intellectual property law firm that represents clients that range from small businesses to private equity and from start-ups to multi-billion dollar international corporations. The firm provides IP risk, management advice in connection with technology-based transactions, whether acquisition- or license-based, product development strategy and competitive market positioning. Our scientific expertise and institutional knowledge cover the fields of medtech, electrical engineering, telecommunications, software, material properties, heat transfer and thermodynamics, optics, geophysical exploration, high-energy particle applications and consumer products. The firm is entrusted with IP matters that go before the U.S. Patent and Trademark Office, including the Patent Trials and Appeals Board, the U.S. District Courts and, through decades of collaboration with trusted foreign associates worldwide, courts and rightsgranting agencies throughout the world.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries.
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Categories